KONTEX

Taipei City, Taiwan1–10 employeeskontex.ioLinkedIn

Brain-computer interfaces
EEG and neural monitoring
Neuroscience research tools

Founded in 2019 and headquartered in Taipei, Taiwan, KonteX develops neurotechnology tools for neuroscience research. Its portfolio includes neural recording headstages, data acquisition systems, adapters, electrode interface boards, and instruments designed to support precise, reliable, and affordable experimentation.

Visit kontex.io ↗

Employees: 1–10

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

KonteX’s available company profile describes a neuroscience research equipment and software business founded in 2019 and based in Taipei, Taiwan. Its portfolio spans neural recording and stimulation hardware, data acquisition systems, connectivity components, and supporting software and services. Named products include the XDAQ data acquisition system, X-Headstage neural interfaces, Commutator PRO, and an in-vitro microelectrode array platform. KC Kong is identified as the company’s founder and brings prior experience co-founding NeuroNexus Technologies. It also provides no funding amount or named investor. The clearest company milestone with a date is its 2019 founding; the product range and founder background provide context for its focus on practical tools for neuroscience experimentation, rather than evidence of a newly announced expansion.

Market position

KonteX operates at the intersection of neuroscience research instruments, embedded hardware, medical devices, and software. Its stated focus is research equipment for neural recording and electrical stimulation, including support for Neuropixels experiments, optogenetics, and in-vitro microelectrode array studies. The product mix combines acquisition systems, headstages, cable management, adapters, electrode interface boards, and related software and services. This modular breadth is a potential point of differentiation: researchers can source several connected components and customization or repair support from one specialist supplier. The company is described as private, with an employee-size band of 1–10 and no funding rounds or valuation available; the information therefore does not support a comparison based on scale, capital, or market share. Its position is best characterized as a focused supplier serving specialist laboratory workflows, rather than a broad clinical-device provider. The stated ambition to translate research technologies toward clinical applications should not be mistaken for evidence of established clinical deployment.

Growth & opportunities

KonteX was founded in 2019, and its disclosed portfolio covers multiple parts of the neuroscience research workflow: neural interfaces, data acquisition, stimulation, probe connectivity, cable management, in-vitro MEA equipment, software, and technical services. The company is listed in the 1–10 employee band, with no hiring news, reported layoffs, funding rounds, or valuation information to indicate a measurable change in scale. KC Kong’s prior experience co-founding NeuroNexus Technologies is relevant founder background, but it is not evidence of current commercial growth. Overall, the profile supports a picture of a specialist company building a broad set of compatible tools from its Taipei base; it does not support claims about revenue, adoption, headcount growth, or financing momentum. Further dated operating milestones would be needed to assess acceleration or changes in trajectory.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes KONTEX distinct

reccy insights

What makes KONTEX distinct

01Combines experience across neurotechnology, telecommunications, medical instruments, PC manufacturing, semiconductors, and packaging.
02Founded by KC Kong, who previously co-founded NeuroNexus Technologies and has experience in bioMEMS and neural interfaces.
03Offers a modular ecosystem of headstages, data acquisition systems, adapters, and accessories for different research setups.
04Based in Taipei, Taiwan, with access to local semiconductor and medical-device manufacturing partners.
05Aims to translate neuroscience research technologies into practical applications, including potential clinical settings.

Technology & products5

Technology & products

XDAQ
A data acquisition system for neural recording, electrical stimulation, Neuropixels, optogenetics, and synchronized video capture.
X-Headstage
A neural interface for recording from multiple electrodes and, in selected models, delivering electrical stimulation.
Commutator PRO
A motorized cable-management system for electrophysiology experiments using passive probes and Neuropixels.
In-vitro MEA Platform
An in-vitro microelectrode array platform for neural signal recording and electrical stimulation in laboratory environments.
Neural Connectivity Components and Services
Adapters, electrode interface boards, cables, accessories, instruments, firmware upgrades, repairs, and custom design services for neuroscience equipment.

Show all 5 products

+ 2 more: In-vitro MEA Platform, Neural Connectivity Components and Services

Similar companies

Show all 6 companies

About KONTEX

Products: XDAQ, X-Headstage, Commutator PRO, In-vitro MEA Platform, Neural Connectivity Components and Services
Leadership: KC Kong, Founder
Focus areas: Neurotechnology, neuroscience, neural recording, research instruments, medical devices, data acquisition, electrophysiology, hardware
Headquarters: Taipei City, Taiwan
Employees: 1–10